Clinical Trial Update: A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effect of Deucravacitinib on quality of life in participants with plaque psoriasis in a community setting; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2025-09-10